• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有或无血栓预防措施的住院内科和外科患者中 Wells 评分预测深静脉血栓的表现:R-WITT 研究。

Performance of the Wells score in predicting deep vein thrombosis in medical and surgical hospitalized patients with or without thromboprophylaxis: The R-WITT study.

机构信息

Vascular Medicine Department, University Hospital Poitiers, Poitiers, France.

Vascular Medicine Department, University Hospital Nîmes, Nîmes, Languedoc-Roussillon, France.

出版信息

Vasc Med. 2021 Jun;26(3):288-296. doi: 10.1177/1358863X21994672. Epub 2021 Mar 22.

DOI:10.1177/1358863X21994672
PMID:33749393
Abstract

The Wells score had shown weak performance to determine pre-test probability of deep vein thrombosis (DVT) for inpatients. So, we evaluated the impact of thromboprophylaxis on the utility of the Wells score for risk stratification of inpatients with suspected DVT. This bicentric cross-sectional study from February 1, 2018 to January 31, 2019 included consecutive medical and surgical inpatients who underwent lower limb ultrasound study for suspected DVT. Wells score clinical predictors were assessed by both ordering and vascular physicians within 24 h after clinical suspicion of DVT. Primary outcome was the Wells score's accuracy for pre-test risk stratification of suspected DVT, accounting for anticoagulation (AC) treatment (thromboprophylaxis for ⩾ 72 hours or long-term anticoagulation). We compared prevalence of proximal DVT among the low, moderate and high pre-test probability groups. The discrimination accuracy was defined as area under the receiver operating characteristics (ROC) curve. Of the 415 included patients, 30 (7.2%) had proximal DVT. Prevalence of proximal DVT was lower than expected in all pre-test probability groups. The prevalence in low, moderate and high pre-test probability groups was 0.0%, 3.1% and 8.2% ( = 0.22) and 1.7%, 4.2% and 25.8% ( < 0.001) for inpatients with or without AC, respectively. Area under ROC curves for discriminatory accuracy of the Wells score, for risk of proximal DVT with or without AC, was 0.72 and 0.88, respectively. The Wells score performed poorly for discrimination of risk for proximal DVT in hospitalized patients with AC but performed reasonably well among patients without AC; and showed low inter-rater reliability between physicians.

摘要

威尔斯评分在预测住院患者深静脉血栓(DVT)的术前患病概率方面表现不佳。因此,我们评估了血栓预防措施对 Wells 评分用于疑似 DVT 住院患者风险分层的影响。这是一项 2018 年 2 月 1 日至 2019 年 1 月 31 日进行的、包含连续住院患者的、以中心为基础的、前瞻性研究,这些患者因疑似 DVT 而行下肢超声检查。在怀疑 DVT 后 24 小时内,临床医生和血管科医生都评估了 Wells 评分的临床预测因素。主要结果是 Wells 评分对疑似 DVT 的术前风险分层的准确性,同时考虑了抗凝治疗(AC)(≥72 小时的血栓预防或长期抗凝)。我们比较了低、中、高术前概率组中近端 DVT 的发生率。区分准确性定义为接受者操作特征(ROC)曲线下面积。在 415 例纳入患者中,有 30 例(7.2%)患有近端 DVT。在所有术前概率组中,近端 DVT 的发生率均低于预期。在有或无 AC 的低、中、高术前概率组中,近端 DVT 的发生率分别为 0.0%、3.1%和 8.2%(=0.22)和 1.7%、4.2%和 25.8%(<0.001)。在有或无 AC 的情况下,ROC 曲线下面积分别为 0.72 和 0.88,用于预测近端 DVT 的 Wells 评分的区分准确性。威尔斯评分在预测有或无 AC 的住院患者近端 DVT 风险时表现不佳,但在无 AC 的患者中表现相当好;并且两位医生之间的评分一致性较差。

相似文献

1
Performance of the Wells score in predicting deep vein thrombosis in medical and surgical hospitalized patients with or without thromboprophylaxis: The R-WITT study.有或无血栓预防措施的住院内科和外科患者中 Wells 评分预测深静脉血栓的表现:R-WITT 研究。
Vasc Med. 2021 Jun;26(3):288-296. doi: 10.1177/1358863X21994672. Epub 2021 Mar 22.
2
Are Patients With Morbid Obesity at Increased Risk of Pulmonary Embolism or Proximal Deep Vein Thrombosis After Lower Limb Arthroplasty? A Large-database Study.肥胖症患者下肢关节置换术后发生肺栓塞或近端下肢深静脉血栓的风险是否增加?一项大数据库研究。
Clin Orthop Relat Res. 2024 Jan 1;482(1):115-124. doi: 10.1097/CORR.0000000000002742. Epub 2023 Jul 4.
3
Pentasaccharides for the prevention of venous thromboembolism.用于预防静脉血栓栓塞的五糖
Cochrane Database Syst Rev. 2016 Oct 31;10(10):CD005134. doi: 10.1002/14651858.CD005134.pub3.
4
Antiplatelet agents for the treatment of deep venous thrombosis.抗血小板药物治疗深静脉血栓形成。
Cochrane Database Syst Rev. 2022 Jul 25;7(7):CD012369. doi: 10.1002/14651858.CD012369.pub2.
5
Building and Verifying a Prediction Model for Deep Vein Thrombosis Among Spinal Cord Injury Patients Undergoing Inpatient Rehabilitation.构建并验证脊髓损伤住院康复患者深静脉血栓形成的预测模型
World Neurosurg. 2025 Feb;194:123451. doi: 10.1016/j.wneu.2024.11.034. Epub 2024 Dec 6.
6
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.延长疗程的抗凝剂用于预防全髋关节或膝关节置换术后或髋部骨折修复后的静脉血栓栓塞。
Cochrane Database Syst Rev. 2016 Mar 30;3(3):CD004179. doi: 10.1002/14651858.CD004179.pub2.
7
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3.
8
Thrombolysis for acute deep vein thrombosis.急性深静脉血栓形成的溶栓治疗
Cochrane Database Syst Rev. 2016 Nov 10;11(11):CD002783. doi: 10.1002/14651858.CD002783.pub4.
9
Angioplasty or stenting for deep venous thrombosis.血管成形术或支架置入术治疗深静脉血栓形成。
Cochrane Database Syst Rev. 2025 Feb 19;2(2):CD011468. doi: 10.1002/14651858.CD011468.pub2.
10
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis.口服直接凝血酶抑制剂或口服因子 Xa 抑制剂与传统抗凝剂治疗深静脉血栓形成的比较。
Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD010956. doi: 10.1002/14651858.CD010956.pub3.

引用本文的文献

1
Thrombin generation indices and Wells score predict pulmonary embolism in patients with acute exacerbation of chronic obstructive pulmonary disease.凝血酶生成指数和Wells评分可预测慢性阻塞性肺疾病急性加重患者的肺栓塞。
Clinics (Sao Paulo). 2025 Feb 27;80:100582. doi: 10.1016/j.clinsp.2025.100582. eCollection 2025.
2
Risk Prediction Models for Preoperative Deep Vein Thrombosis in Older Patients with Hip Fracture: A Systematic Review and Meta-Analysis.老年髋部骨折患者术前深静脉血栓形成的风险预测模型:系统评价和荟萃分析。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241285565. doi: 10.1177/10760296241285565.
3
Utilization of the Caprini risk assessment model(RAM) to predict venous thromboembolism after primary hip and knee arthroplasty: an analysis of the Healthcare Cost and Utilization Project(HCUP).
利用Caprini风险评估模型预测初次髋膝关节置换术后静脉血栓栓塞:医疗成本与利用项目(HCUP)分析
Thromb J. 2024 Jul 24;22(1):68. doi: 10.1186/s12959-024-00633-4.
4
Risk Scores in Venous Thromboembolism Guidelines of ESC, ACCP, and ASH: An Updated Review.ESC、ACCP 和 ASH 静脉血栓栓塞症指南中的风险评分:更新综述。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241263856. doi: 10.1177/10760296241263856.
5
In-Hospital versus Out-of-Hospital Pulmonary Embolism: Clinical Characteristics, Biochemical Markers and Echocardiographic Indices.院内与院外肺栓塞:临床特征、生化标志物及超声心动图指标
J Cardiovasc Dev Dis. 2024 Mar 28;11(4):103. doi: 10.3390/jcdd11040103.